Provided by Tiger Fintech (Singapore) Pte. Ltd.

Oculis

17.00
-1.0500-5.82%
Post-market: 17.000.00000.00%16:05 EDT
Volume:63.80K
Turnover:1.10M
Market Cap:798.06M
PE:-7.26
High:18.04
Open:18.04
Low:16.77
Close:18.05
Loading ...

TransMedics Group’s OCS Drives Structural Transformation in Liver Transplantation with Increased DCD Liver Utilization

TIPRANKS
·
22 Apr

Oculis Holding Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
17 Apr

Oculis Holding Ag : H.c. Wainwright Raises Target Price to $32 From $29

THOMSON REUTERS
·
17 Apr

Oculis and EURETINA Announce the 2025 Ramin Tadayoni Award

GlobeNewswire
·
17 Apr

Oculis Holding’s Promising Future: Advancements in Neuroprotection, Dry Eye Treatment, and Diabetic Macular Edema

TIPRANKS
·
17 Apr

Oculis Holding (OCS) Receives a Buy from Bank of America Securities

TIPRANKS
·
16 Apr

Oculis Holding AG Unveils Key Clinical Updates and Future Outlook at R&D Day

TIPRANKS
·
16 Apr

Oculis Completes Enrollment in Late-Stage Diabetic Macular Edema Trials

MT Newswires Live
·
10 Apr

Oculis Completes Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular Edema

GlobeNewswire
·
10 Apr

Oculis Down Over 11%, on Track for Largest Percent Decrease Since May 2023 -- Data Talk

Dow Jones
·
05 Apr

Oculis to Host In-Person and Virtual R&D Day on Key Business Updates and the Development Plans for Privosegtor (OCS-05) in Acute Optic Neuritis and Beyond

GlobeNewswire
·
01 Apr

Lumentum to Showcase Cutting-Edge Optical Innovations for Cloud, AI, and Networking Infrastructure at OFC 2025

Business Wire
·
28 Mar

New nipocalimab data and real-world research at AAN 2025 highlight positive Phase 3 results and commitment to people living with generalized myasthenia gravis (gMG)

PR Newswire
·
26 Mar

1 Compelling Reason to Buy and Hold TransMedics Group Stock Forever

Motley Fool
·
22 Mar

Oculis Publishes Notifications of Transactions by Person Discharging Managerial Responsibilities

GlobeNewswire
·
21 Mar

Lionel Carnot Spends CHF326k On Oculis Holding Stock

Simply Wall St.
·
19 Mar

1 Turnaround Growth Stock Down 60% That Could Double, According to Wall Street

Motley Fool
·
19 Mar

Coherent Introduces 2D Collimator Array for Optical Circuit Switches

GlobeNewswire
·
18 Mar

Oculis Holding’s Promising Pipeline and Strategic FDA Alignments Support Buy Rating

TIPRANKS
·
17 Mar

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities

GlobeNewswire
·
15 Mar